Ant’s Rant – The First of Many
There’s been a lot of hot air blowing around lately about Bill Gates’s decision to invest $10M in our friends at Schrodinger. Some have even suggested that this might mean a return to the heady days of...
View ArticleThe Rant Goes On…
In August, I gave a talk at the Boston ACS meeting about the contribution of academics to molecular modeling. Okay, their lack of contribution to molecular modeling. I might even have had a slide that...
View ArticleThe Bayh-Dole Act
In my last post, I ranted on about the problems surrounding contributions by academics to molecular modeling, and cited as a particular issue the Bayh-Dole Act (BD), which enabled and encouraged...
View ArticleWhat Is Really Killing Pharma
Sometimes it’s frustrating being in the business of servicing an industry so manifestly important and so manifestly stupid. I started OpenEye to help those I had come to know in pharma do a better job,...
View ArticleCuring Pharma: (1) Avoiding Hype-based Science
I’ve been thinking a lot lately about Jacques Tati’s masterful 1967 work Play Time, which describes an antiseptic, colorless and angular world of the future, a bleak world that only relents when the...
View ArticleOn the Passing of Andrew Grant
Of the many reasons to restart my blog I expected least the death of a friend. As many of you know, Andrew Grant of AstraZeneca and long-time OpenEye collaborator, passed away on the 29th of December....
View ArticleA Different Conference
As many of you know, I’m organizing the 2013 CADD Gordon conference (July 21st to 25th, Mount Snow, Vermont). A Gordon conference is rare opportunity to actually “confer”, and there’s a lot to talk...
View ArticleCD and MD
When the recent Nobel Prize for Chemistry was announced, going to Karplus, Levitt and Warshel I assumed it must have been for “Services to Molecular Dynamics”. As such, I joined the debate on Derek...
View ArticleDave Weininger’s passing
I stopped writing blogs after my last one, the one where I pointed out that some in the MD world aren’t paying close attention to the scientific principles of test and verification, mainly because...
View Article